ifestyle change, self-management, and problem solving in daily life in cancer survivors; an online portal for change and support.
- Conditions
- Tertiary Prevention, Cancer survivors, Cancer Aftercare, Disease self-management, Social support, Lifestyle, Quality of life, Psychosocial distress.
- Registration Number
- NL-OMON29153
- Lead Sponsor
- Open University of the Netherlands, Maastricht University
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
1. 18 years of age or older;
2. Patients who were previously diagnosed with cancer;
Exclusion Criteria
Patients with a serious medical, psychiatric, or cognitive disease that would interfere with participation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The extent of psychosocial distress;<br /><br>2. Health related quality of life in patients.<br><br /><br /><br>Psychosocial distress will be measured with the General Health Questionnaire – 12 item version (GHQ-12) and the Hospital Anxiety and Depression Scale (HADS). Quality of life will be measured with the European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire (EORTC QLQ-C30). Both primary outcomes will be assessed at all time points.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do lifestyle modifications in cancer aftercare influence molecular pathways like inflammation or oxidative stress in tertiary prevention?
What is the comparative effectiveness of online self-management portals versus traditional in-person aftercare programs for cancer survivors' quality of life?
Which biomarkers, such as cortisol or inflammatory markers, predict response to digital lifestyle interventions in cancer survivors?
What are the potential adverse events of digital problem-solving therapy in cancer aftercare, and how are they managed compared to in-person methods?
How does the NL-OMON29153 online portal compare to other digital health platforms in addressing psychosocial distress and lifestyle modification in cancer survivors?